Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L.

Source:http://linkedlifedata.com/resource/pubmed/id/14678032

Download in:

View as

General Info

PMID
14678032